Cancer Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts

Market Segmentation

• Cancer Diagnostics Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Instruments
    • Pathology-based Instruments
      • Slide Staining Systems
      • Tissue Processing Systems
      • Cell Processors
      • PCR Instruments
      • NGS Instruments
      • Microarrays
      • Other Pathology-based Instruments
    • Imaging Instruments
    • Others
  • Consumables
    • Antibodies
    • Kits & reagents
    • Probes
    • Others
  • Services
• Cancer Diagnostics Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • IVD
    • By Type
      • Diagnosis
      • Early Detection
      • Therapy Selection
      • Monitoring
    • By Technology
      • Polymerase Chain Reaction (PCR)
      • In Situ Hybridization (ISH)
      • Immunohistochemistry (IHC)
      • Next-generation Sequencing (NGS)
      • Microarrays
      • Flow Cytometry
      • Immunoassays
      • Other IVD Testing Technologies
  • LDT
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
    • Mammography
    • Ultrasound
    • Others
• Cancer Diagnostics Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others
• Cancer Diagnostics End use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals
  • Laboratories
  • Others
• Cancer Diagnostics Test Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Biopsy
    • Fine-needle Aspiration
    • Core Biopsy
    • Surgical Biopsy
    • Skin Biopsy /Punch Biopsy
    • Others
  • Others
• Cancer Diagnostics Coverage Outlook (Revenue, USD Billion, 2018 - 2030)
  • Public Insurance
  • Private Insurance
• Cancer Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • North America Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
      • Instruments
        • Pathology-based Instruments
          • Slide Staining Systems
          • Tissue Processing Systems
          • Cell Processors
          • PCR Instruments
          • NGS Instruments
          • Microarrays
          • Other Pathology-based Instruments
        • Imaging Instruments
        • Others
      • Consumables
        • Antibodies
        • Kits & reagents
        • Probes
        • Others
      • Services
    • North America Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
      • IVD
        • By Type
          • Diagnosis
          • Early Detection
          • Therapy Selection
          • Monitoring
        • By Technology
          • Polymerase Chain Reaction (PCR)
          • In Situ Hybridization (ISH)
          • Immunohistochemistry (IHC)
          • Next-generation Sequencing (NGS)
          • Microarrays
          • Flow Cytometry
          • Immunoassays
          • Other IVD Testing Technologies
      • LDT
      • Imaging
        • Magnetic Resonance Imaging (MRI)
        • Computed Tomography (CT)
        • Positron Emission Tomography (PET)
        • Mammography
        • Ultrasound
        • Others
    • North America Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Lung Cancer
      • Prostate Cancer
      • Skin Cancer
      • Blood Cancer
      • Kidney Cancer
      • Liver Cancer
      • Pancreatic Cancer
      • Ovarian Cancer
      • Others
    • North America Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
      • Hospitals
      • Laboratories
      • Others
    • North America Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
      • Biopsy
        • Fine-needle Aspiration
        • Core Biopsy
        • Surgical Biopsy
        • Skin Biopsy /Punch Biopsy
        • Others
      • Others
    • North America Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
      • Public Insurance
      • Private Insurance
    • U.S.
      • U.S. Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • U.S. Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • U.S. Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • U.S. Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • U.S. Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • U.S. Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Canada
      • Canada Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Canada Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Canada Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Canada Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Canada Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Canada Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
  • Europe
    • Europe Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
      • Instruments
        • Pathology-based Instruments
          • Slide Staining Systems
          • Tissue Processing Systems
          • Cell Processors
          • PCR Instruments
          • NGS Instruments
          • Microarrays
          • Other Pathology-based Instruments
        • Imaging Instruments
        • Others
      • Consumables
        • Antibodies
        • Kits & reagents
        • Probes
        • Others
      • Services
    • Europe Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
      • IVD
        • By Type
          • Diagnosis
          • Early Detection
          • Therapy Selection
          • Monitoring
        • By Technology
          • Polymerase Chain Reaction (PCR)
          • In Situ Hybridization (ISH)
          • Immunohistochemistry (IHC)
          • Next-generation Sequencing (NGS)
          • Microarrays
          • Flow Cytometry
          • Immunoassays
          • Other IVD Testing Technologies
      • LDT
      • Imaging
        • Magnetic Resonance Imaging (MRI)
        • Computed Tomography (CT)
        • Positron Emission Tomography (PET)
        • Mammography
        • Ultrasound
        • Others
    • Europe Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Lung Cancer
      • Prostate Cancer
      • Skin Cancer
      • Blood Cancer
      • Kidney Cancer
      • Liver Cancer
      • Pancreatic Cancer
      • Ovarian Cancer
      • Others
    • Europe Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
      • Hospitals
      • Laboratories
      • Others
    • Europe Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
      • Biopsy
        • Fine-needle Aspiration
        • Core Biopsy
        • Surgical Biopsy
        • Skin Biopsy /Punch Biopsy
        • Others
      • Others
    • Europe Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
      • Public Insurance
      • Private Insurance
    • Germany
      • Germany Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Germany Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Germany Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Germany Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Germany Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Germany Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • UK
      • UK Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • UK Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • UK Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • UK Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • UK Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • UK Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • France
      • France Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • France Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • France Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • France Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • France Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • France Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Italy
      • Italy Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Italy Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Italy Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Italy Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Italy Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Italy Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Spain
      • Spain Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Spain Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Spain Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Spain Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Spain Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Spain Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Denmark
      • Denmark Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Denmark Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Denmark Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Denmark Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Denmark Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Denmark Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Sweden
      • Sweden Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Sweden Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Sweden Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Sweden Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Sweden Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Sweden Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Norway
      • Norway Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Norway Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Norway Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Norway Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Norway Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Norway Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
  • Asia Pacific
    • Asia Pacific Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
      • Instruments
        • Pathology-based Instruments
          • Slide Staining Systems
          • Tissue Processing Systems
          • Cell Processors
          • PCR Instruments
          • NGS Instruments
          • Microarrays
          • Other Pathology-based Instruments
        • Imaging Instruments
        • Others
      • Consumables
        • Antibodies
        • Kits & reagents
        • Probes
        • Others
      • Services
    • Asia Pacific Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
      • IVD
        • By Type
          • Diagnosis
          • Early Detection
          • Therapy Selection
          • Monitoring
        • By Technology
          • Polymerase Chain Reaction (PCR)
          • In Situ Hybridization (ISH)
          • Immunohistochemistry (IHC)
          • Next-generation Sequencing (NGS)
          • Microarrays
          • Flow Cytometry
          • Immunoassays
          • Other IVD Testing Technologies
      • LDT
      • Imaging
        • Magnetic Resonance Imaging (MRI)
        • Computed Tomography (CT)
        • Positron Emission Tomography (PET)
        • Mammography
        • Ultrasound
        • Others
    • Asia Pacific Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Lung Cancer
      • Prostate Cancer
      • Skin Cancer
      • Blood Cancer
      • Kidney Cancer
      • Liver Cancer
      • Pancreatic Cancer
      • Ovarian Cancer
      • Others
    • Asia Pacific Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
      • Hospitals
      • Laboratories
      • Others
    • Asia Pacific Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
      • Biopsy
        • Fine-needle Aspiration
        • Core Biopsy
        • Surgical Biopsy
        • Skin Biopsy /Punch Biopsy
        • Others
      • Others
    • Asia Pacific Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
      • Public Insurance
      • Private Insurance
    • China
      • China Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • China Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • China Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • China Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • China Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • China Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Japan
      • Japan Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Japan Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Japan Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Japan Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Japan Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Japan Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • India
      • India Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • India Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • India Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • India Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • India Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • India Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Thailand
      • Thailand Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Thailand Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Thailand Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Thailand Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Thailand Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Thailand Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • South Korea
      • South Korea Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • South Korea Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • South Korea Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • South Korea Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • South Korea Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • South Korea Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Australia
      • Australia Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Australia Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Australia Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Australia Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Australia Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Australia Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
  • Latin America
    • Latin America Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
      • Instruments
        • Pathology-based Instruments
          • Slide Staining Systems
          • Tissue Processing Systems
          • Cell Processors
          • PCR Instruments
          • NGS Instruments
          • Microarrays
          • Other Pathology-based Instruments
        • Imaging Instruments
        • Others
      • Consumables
        • Antibodies
        • Kits & reagents
        • Probes
        • Others
      • Services
    • Latin America Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
      • IVD
        • By Type
          • Diagnosis
          • Early Detection
          • Therapy Selection
          • Monitoring
        • By Technology
          • Polymerase Chain Reaction (PCR)
          • In Situ Hybridization (ISH)
          • Immunohistochemistry (IHC)
          • Next-generation Sequencing (NGS)
          • Microarrays
          • Flow Cytometry
          • Immunoassays
          • Other IVD Testing Technologies
      • LDT
      • Imaging
        • Magnetic Resonance Imaging (MRI)
        • Computed Tomography (CT)
        • Positron Emission Tomography (PET)
        • Mammography
        • Ultrasound
        • Others
    • Latin America Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Lung Cancer
      • Prostate Cancer
      • Skin Cancer
      • Blood Cancer
      • Kidney Cancer
      • Liver Cancer
      • Pancreatic Cancer
      • Ovarian Cancer
      • Others
    • Latin America Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
      • Hospitals
      • Laboratories
      • Others
    • Latin America Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
      • Biopsy
        • Fine-needle Aspiration
        • Core Biopsy
        • Surgical Biopsy
        • Skin Biopsy /Punch Biopsy
        • Others
      • Others
    • Latin America Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
      • Public Insurance
      • Private Insurance
    • Brazil
      • Brazil Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Brazil Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Brazil Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Brazil Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Brazil Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Brazil Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Mexico
      • Mexico Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Mexico Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Mexico Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Mexico Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Mexico Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Mexico Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Argentina
      • Argentina Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Argentina Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Argentina Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Argentina Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Argentina Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Argentina Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
  • Middle East and Africa (MEA)
    • Middle East and Africa Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
      • Instruments
        • Pathology-based Instruments
          • Slide Staining Systems
          • Tissue Processing Systems
          • Cell Processors
          • PCR Instruments
          • NGS Instruments
          • Microarrays
          • Other Pathology-based Instruments
        • Imaging Instruments
        • Others
      • Consumables
        • Antibodies
        • Kits & reagents
        • Probes
        • Others
      • Services
    • Middle East and Africa Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
      • IVD
        • By Type
          • Diagnosis
          • Early Detection
          • Therapy Selection
          • Monitoring
        • By Technology
          • Polymerase Chain Reaction (PCR)
          • In Situ Hybridization (ISH)
          • Immunohistochemistry (IHC)
          • Next-generation Sequencing (NGS)
          • Microarrays
          • Flow Cytometry
          • Immunoassays
          • Other IVD Testing Technologies
      • LDT
      • Imaging
        • Magnetic Resonance Imaging (MRI)
        • Computed Tomography (CT)
        • Positron Emission Tomography (PET)
        • Mammography
        • Ultrasound
        • Others
    • Middle East and Africa Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Lung Cancer
      • Prostate Cancer
      • Skin Cancer
      • Blood Cancer
      • Kidney Cancer
      • Liver Cancer
      • Pancreatic Cancer
      • Ovarian Cancer
      • Others
    • Middle East and Africa Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
      • Hospitals
      • Laboratories
      • Others
    • Middle East and Africa Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
      • Biopsy
        • Fine-needle Aspiration
        • Core Biopsy
        • Surgical Biopsy
        • Skin Biopsy /Punch Biopsy
        • Others
      • Others
    • Middle East and Africa Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
      • Public Insurance
      • Private Insurance
    • South Africa
      • South Africa Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • South Africa Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • South Africa Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • South Africa Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • South Africa Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • South Africa Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Saudi Arabia
      • Saudi Arabia Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Saudi Arabia Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Saudi Arabia Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Saudi Arabia Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Saudi Arabia Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Saudi Arabia Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • UAE
      • UAE Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • UAE Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • UAE Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • UAE Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • UAE Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • UAE Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance
    • Kuwait
      • Kuwait Cancer Diagnostics Market, By Product 2018 - 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Kuwait Cancer Diagnostics Market, By Type 2018 - 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Kuwait Cancer Diagnostics Market, by Application 2018 - 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Kuwait Cancer Diagnostics Market, by End use 2018 - 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Kuwait Cancer Diagnostics Market, by Test Type 2018 - 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Kuwait Cancer Diagnostics Market, by Coverage 2018 - 2030 (USD Billion)
        • Public Insurance
        • Private Insurance

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance